- Home
- KLXE vs ASRT Comparison
KLXE vs ASRT Comparison
Compare KLXE & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- ASRT
- Stock Information
- Founded
- KLXE 2018
- ASRT 1995
- Country
- KLXE United States
- ASRT United States
- Employees
- KLXE N/A
- ASRT N/A
- Industry
- KLXE Oilfield Services/Equipment
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- ASRT Health Care
- Exchange
- KLXE Nasdaq
- ASRT Nasdaq
- Market Cap
- KLXE 90.4M
- ASRT 105.8M
- IPO Year
- KLXE N/A
- ASRT 1997
- Fundamental
- Price
- KLXE $5.58
- ASRT $0.84
- Analyst Decision
- KLXE Hold
- ASRT Strong Buy
- Analyst Count
- KLXE 1
- ASRT 4
- Target Price
- KLXE $4.50
- ASRT $3.19
- AVG Volume (30 Days)
- KLXE 117.6K
- ASRT 814.4K
- Earning Date
- KLXE 10-31-2024
- ASRT 11-11-2024
- Dividend Yield
- KLXE N/A
- ASRT N/A
- EPS Growth
- KLXE N/A
- ASRT N/A
- EPS
- KLXE N/A
- ASRT N/A
- Revenue
- KLXE $738,000,000.00
- ASRT $125,763,000.00
- Revenue This Year
- KLXE N/A
- ASRT N/A
- Revenue Next Year
- KLXE $4.79
- ASRT $4.68
- P/E Ratio
- KLXE N/A
- ASRT N/A
- Revenue Growth
- KLXE N/A
- ASRT N/A
- 52 Week Low
- KLXE $4.18
- ASRT $0.73
- 52 Week High
- KLXE $12.13
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- KLXE 57.39
- ASRT 32.60
- Support Level
- KLXE $5.56
- ASRT $0.82
- Resistance Level
- KLXE $6.33
- ASRT $1.07
- Average True Range (ATR)
- KLXE 0.39
- ASRT 0.07
- MACD
- KLXE 0.18
- ASRT -0.02
- Stochastic Oscillator
- KLXE 69.95
- ASRT 13.09
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.